Technical Analysis for REPL - Replimune Group, Inc.

Grade Last Price % Change Price Change
F 6.44 -4.17% -0.28
REPL closed down 4.17 percent on Friday, May 17, 2024, on approximately normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
180 Bearish Setup Bearish Swing Setup 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Earnings Movers Other 0.00%
20 DMA Support Bullish -4.17%
Hammer Candlestick Bullish -4.17%
Lizard Bullish Bullish Day Trade Setup -4.17%
Bollinger Band Squeeze Range Contraction -4.17%
Earnings Movers Other -4.17%
Gapped Down Weakness -4.17%

   Recent Intraday Alerts

Alert Time
Down 3% 2 days ago
60 Minute Opening Range Breakdown 2 days ago
Fell Below 20 DMA 2 days ago
Up 3% 2 days ago
Up 2% 2 days ago

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Replimune Group, Inc. is a clinical-stage biotechnology company. The Company is engaged in the field of oncolytic immunotherapy to treat the cancer patients. The Company applies its Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The Company is focused on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP, RP2, and RP3. The Company is focused on Phase 1/2 clinical trial with its lead product candidate, RP1, in approximately 150 patients with a range of solid tumors.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Solid Tumors Immune System Immunotherapy Cancer Treatment Virotherapy Immunotherapy Products Oncolytic Virus Experimental Cancer Treatments Transgene Sa Akseli Hemminki Rp1

Is REPL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 24.81
52 Week Low 5.86
Average Volume 905,724
200-Day Moving Average 11.23
50-Day Moving Average 7.30
20-Day Moving Average 6.58
10-Day Moving Average 6.70
Average True Range 0.44
RSI (14) 41.52
ADX 19.25
+DI 17.93
-DI 22.43
Chandelier Exit (Long, 3 ATRs) 6.12
Chandelier Exit (Short, 3 ATRs) 7.17
Upper Bollinger Bands 7.02
Lower Bollinger Band 6.14
Percent B (%b) 0.34
BandWidth 13.38
MACD Line -0.15
MACD Signal Line -0.19
MACD Histogram 0.0425
Fundamentals Value
Market Cap 395.34 Million
Num Shares 61.4 Million
EPS -3.16
Price-to-Earnings (P/E) Ratio -2.04
Price-to-Sales 0.00
Price-to-Book 1.13
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.23
Resistance 3 (R3) 7.30 7.12 7.10
Resistance 2 (R2) 7.12 6.92 7.08 7.05
Resistance 1 (R1) 6.78 6.79 6.69 6.70 7.01
Pivot Point 6.59 6.59 6.55 6.55 6.59
Support 1 (S1) 6.25 6.39 6.16 6.18 5.87
Support 2 (S2) 6.07 6.27 6.03 5.83
Support 3 (S3) 5.73 6.07 5.78
Support 4 (S4) 5.65